Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial - Concepedia

Concepedia

Publication | Closed Access

Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial

46

Citations

19

References

2015

Year

Ayman Chit, Debbie Becker, Carlos A. DiazGranados, Michael Maschio, Eddy Yau, Michael Drummond

The Lancet Infectious Diseases

VaccinationPreventive MedicineHealth PolicyHealth EconomicsVaccine EfficacyInfluenza VaccinePublic HealthEconomic EvaluationMedicineInfluenza Vaccines

References

	Year	Citations

Page 1